http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006137433-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef2a6d661df17e57ad3155c24188735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05c095f58520a10986a92966e2e3f1db
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
filingDate 2006-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a63c485063f713d775f2434193972381
publicationDate 2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006137433-A1
titleOfInvention Aqueous preparation having levocabastine solubilized therein
abstract A weakly acidic to almost neutral aqueous preparation containing levocabastine, a cyclodextrin and a water-soluble cellulose derivative. A conventional levocabastine suspension preparation needs to be fully shaken to give a homogenous solution before use. However, the inventive levocabastine preparation does not need such an effort since levocabastine is solubilized in the preparation. The levocabastine preparation can be applied to eyes in the form of an eye drop even when contact lens are worn, and therefore is easy to use for a user.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011515477-A
priorityDate 2005-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0037109-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9710805-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000351738-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002348238-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8502767-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9525518-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0605203-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004067614-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07165616-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0472327-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226517688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136081779

Total number of triples: 36.